Enovis CORP

Enovis Corporation is a medical technology company that develops, manufactures, and distributes medical devices across the care continuum, from injury prevention to joint replacement and post-operative rehabilitation. The company operates through two segments: Prevention & Recovery, and Reconstructive. The Prevention & Recovery segment provides orthopedic braces, temperature therapies, bone growth stimulators, compression garments, and pain management equipment. The Reconstructive segment supplies surgical implants, instrumentation, and digital planning technologies for joint replacement and limb reconstruction. Enovis serves orthopedic specialists, surgeons, physical therapists, healthcare systems, and retail consumers.

The company conducts business internationally, with primary geographic markets in the United States and Europe, alongside operations in the Asia-Pacific region. Products are distributed globally through direct sales personnel and independent distributor networks. Enovis also sources raw materials and component parts from diverse global suppliers. The provided text does not state the location of the company's corporate headquarters.

Summary of the business section of Enovis's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025, we employed approximately 7,802 persons, of whom approximately 2,107 were employed in the United States and approximately 5,695 were employed outside of the United States.”